Chronic Neuropathic Pain and Comorbid Depression Syndrome: From Neural Circuit Mechanisms to Treatment.
Yue ZhangHui MaYafan BaiXiaojuan HouYixin YangGu-Yan WangYunfeng LiPublished in: ACS chemical neuroscience (2024)
Chronic neuropathic pain and comorbid depression syndrome (CDS) is a major worldwide health problem that affects the quality of life of patients and imposes a tremendous socioeconomic burden. More than half of patients with chronic neuropathic pain also suffer from moderate or severe depression. Due to the complex pathogenesis of CDS, there are no effective therapeutic drugs available. The lack of research on the neural circuit mechanisms of CDS limits the development of treatments. The purpose of this article is to provide an overview of the various circuits involved in CDS. Notably, activating some neural circuits can alleviate pain and/or depression, while activating other circuits can exacerbate these conditions. Moreover, we discuss current and emerging pharmacotherapies for CDS, such as ketamine. Understanding the circuit mechanisms of CDS may provide clues for the development of novel drug treatments for improved CDS management.
Keyphrases
- neuropathic pain
- quantum dots
- spinal cord
- spinal cord injury
- depressive symptoms
- visible light
- sleep quality
- signaling pathway
- end stage renal disease
- healthcare
- drug induced
- newly diagnosed
- chronic kidney disease
- mental health
- ejection fraction
- case report
- physical activity
- pain management
- risk factors
- prognostic factors
- chronic pain
- high intensity
- adverse drug